"Immunic, Inc. Receives First Regulatory Approval from German Health Authority BfArM to Initiate a Phase 2 Clinical Trial of its Selective Or..."
about Immunic, Inc.
Notified: 16:02 EDT at $12.26
"BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting"
about BioPharmX Corporation
Notified: 16:06 EDT at $0.58
"MEI Pharma and Kyowa Kirin Announce Updated Clinical Data from the Phase 1b Study Evaluating ME-401 on an Intermittent Schedule in Patients ..."
about MEI Pharma, Inc.
Notified: 17:01 EDT at $2.83
"ImmunoGen Announces Initial Data from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Recurrent Ovaria..."
about ImmunoGen, Inc.
Notified: 17:02 EDT at $4.08
"Vaccinex to Present Updated Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) ..."
about Vaccinex, Inc.
Notified: 17:02 EDT at $3.69
"PDS Biotechnology Announces Publication at American Society of Clinical Oncology (ASCO) 2020"
about PDS Biotechnology Corpora..
Notified: 17:05 EDT at $0.95
"Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patie..."
about MEI Pharma, Inc.
Notified: 17:06 EDT at $2.83
"Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl’s Antiproliferative Effects Against Various Cancer Cell Lin..."
about Lexicon Pharmaceuticals, ..
Notified: 17:30 EDT at $2.08
"Oncocyte Announces New Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting Demonstrating That the D..."
about OncoCyte Corp
Notified: 17:51 EDT at $2.72
"Tiziana Life Sciences Announces Data Demonstrating StemPrintER’s Superiority Compared to Oncotype DX in Providing Prognostic Information to ..."
about Tiziana Life Sciences plc
Notified: 02:00 EDT at $4.05
"Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Progr..."
about Verona Pharma plc
Notified: 02:01 EDT at $3.98
"Xeris Pharmaceuticals Signs Exclusive Agreement With Clinigen to Supply and Distribute Gvoke™ Outside the U.S on a Named Patient Basis"
about Xeris Pharmaceuticals, In..
Notified: 03:01 EDT at $3.71
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.